Greater statin dose doesn't boost kidney risk in study

06/19/2013 | HealthDay News

Heart attack survivors who received high doses of cholesterol-lowering statin drugs were no more likely to be hospitalized for kidney injury than those who received low doses, according to a study presented in an American Heart Association webinar. Patients on low- and high-dose statins had comparable concentrations of creatinine, an indicator of kidney function. "These findings provide important reassurance to clinicians that the use of some high-potency statins will not increase the risk of kidney injury," the study's lead author said.

View Full Article in:

HealthDay News

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Product Development Manager, Disposable Medical Products
ASAHI INTECC, Orange County CA R&D Center
Santa Ana, CA
Neurovascular Intervention Product Sales Rep, North East
ASAHI INTECC
Multiple Locations, SL_Multiple Locations
Vice President of Regulatory Affairs
Pentec Health
Boothwyn, PA
Sr Coordinator Clinical Research (US/TA/00/0073/SL) - 1400000AQX
Abbott
Santa Clara, CA
Senior Director, Biostatistics
Edwards Lifesciences
Irvine, CA